Clinical Features Present, Past & Future Prospective of Monkey Pox: A Orthopoxvirus

Abstract

Some issues regarding the potential spread of monkeypox have arisen just as the international world is beginning to recover from the initial alarm that was caused by the probable spread of coronavirus disease 2019 (COVID-19). Despite the fact that parts of Africa have traditionally been more susceptible to monkeypox than other regions of the world, the majority of new cases that have been linked to the outbreak that began in 2022 have been reported in countries located in Europe and the western hemisphere. Despite the fact that a great number of organisations are working on contact-tracing activities at the moment, the origin of this outbreak is still unknown at this time. The monkeypox virus belongs to the family of viruses known as Poxviridae and the genus known as Orthopoxvirus. Following the eradication of smallpox across the globe in the 1970s, news of monkeypox caused widespread worry across the globe. Through vaccination with the smallpox virus, individuals were able to develop cross-immunity against monkeypox. After distribution of the smallpox vaccine was discontinued, the number of outbreaks of monkeypox rose. The monkeypox epidemic that occurred in the United States in 2003 was the first time that the disease gained extensive notice in the media. In spite of its name, the virus known as monkeypox is not transmitted by monkeys. Although a number of different kinds of rodents and other small mammals have been suggested as the primal hosts of the monkeypox virus, the virus's true lineage is still a mystery. The virus that causes monkeypox was first identified in macaque monkeys, which is where the disease was first seen. When monkeypox does transfer from one person to another, it often does so through a person's mucocutaneous lesions or through the respiratory droplets that they expel. However, this only happens very infrequently. However, supporting therapy can be given to reduce symptoms, and medications such tecovirimat may be administered in really severe cases. At this time, there is no specific treatment for patients who have infected the virus; however, supportive treatments can be given. It is debatable whether or not these treatments are successful in reducing symptoms because there are no concrete guidelines to follow in this regard.

Diabetic Retinopathy: Current Understanding, Mechanisms and Treatment Strategies

“…According to another study, SNHG16 enhances hRMEC apoptosis by regulating E2F transcription factor-1 (E2F1) expression through sponging miR-20a-5p [50]. The direct effects of excessive glucose on retinal neurons, glial cells, and blood vessels [51] are mediated by E2F1, and E2F1 regulates oxidative metabolism [52]. More than that, by influencing the miR-195/mitofusin 2 (mfn2) axis, SNHG16 heightens oxidative stress-induced pathological angiogenesis in hMRECs.…”

“…Thus, damage propagates from the original site to neural projections in trans-synaptic degeneration. Retrograde trans-synaptic degeneration in the human visual system, specifically in relation to glaucoma, has only been brought to light in the last few decades, while it has long been established in the motor system and cerebellar pathways [52,53,54]. It exacerbates the vision problems seen in people with a wide range of disorders, including MS [55].…”